bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) traded down 24.3% during trading on Thursday . The company traded as low as $0.28 and last traded at $0.22. 2,372 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 8,107 shares. The stock had previously closed at $0.29.
bioAffinity Technologies Price Performance
The stock’s 50-day moving average price is $0.44 and its 200 day moving average price is $0.71.
About bioAffinity Technologies
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
Further Reading
- Five stocks we like better than bioAffinity Technologies
- Why Are Stock Sectors Important to Successful Investing?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- How to Invest in Insurance Companies: A Guide
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Insider Buying Explained: What Investors Need to Know
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
